Notice Information
Notice Title
Supply agreement SARS-CoV-2 mRNA Vaccine
Notice Description
The procurement of the mRNA-1273 vaccine.
Lot Information
Lot 1
The procurement of the mRNA-1273 vaccine. Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors . Contract end date is being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). The contract end date is variable based on production and delivery of the requirement. There are significant challenges to overcome and the end date may not be a true reflection, setting unrealistic expectation for the public and in the market. Provision of the contract term may provide valuable information to competitors that may impact negotiations or future competition in the market. Sub-contractor details are being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). This information is very sensitive given potential for targeting and disruption of the activities at the facilities which would be contrary to public interest as these activities are critical to success and delivery of the requirement. Please see linked the original notice published on Contracts Finder: https://www.contractsfinder.service.gov.uk/Notice/8930d6c5-354d-44d0-8540-c134fe59aa0a
Procurement Information
The award of the contract to Moderna is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)).
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-037c5e
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/030205-2022
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33651600 - Vaccines
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 26 Oct 20223 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 30 Nov 20214 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- BUSINESS ENERGY AND INDUSTRIAL STRATEGY
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LONDON
- Postcode
- SW1H 0ET
- Post Town
- South West London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI3 Inner London - West
- Small Region (ITL 3)
- TLI35 Westminster and City of London
- Delivery Location
- Not specified
-
- Local Authority
- Westminster
- Electoral Ward
- St James's
- Westminster Constituency
- Cities of London and Westminster
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-037c5e-2022-10-26T14:26:31+01:00",
"date": "2022-10-26T14:26:31+01:00",
"ocid": "ocds-h6vhtk-037c5e",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-037c5e",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "Supply agreement SARS-CoV-2 mRNA Vaccine",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33651600",
"description": "Vaccines"
},
"mainProcurementCategory": "goods",
"description": "The procurement of the mRNA-1273 vaccine.",
"lots": [
{
"id": "1",
"description": "The procurement of the mRNA-1273 vaccine. Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors . Contract end date is being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). The contract end date is variable based on production and delivery of the requirement. There are significant challenges to overcome and the end date may not be a true reflection, setting unrealistic expectation for the public and in the market. Provision of the contract term may provide valuable information to competitors that may impact negotiations or future competition in the market. Sub-contractor details are being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). This information is very sensitive given potential for targeting and disruption of the activities at the facilities which would be contrary to public interest as these activities are critical to success and delivery of the requirement. Please see linked the original notice published on Contracts Finder: https://www.contractsfinder.service.gov.uk/Notice/8930d6c5-354d-44d0-8540-c134fe59aa0a",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_EXTREME_URGENCY",
"description": "Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive"
}
],
"procurementMethodRationale": "The award of the contract to Moderna is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c))."
},
"awards": [
{
"id": "030205-2022-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-66810",
"name": "Moderna Switzerland GmbH"
}
]
}
],
"parties": [
{
"id": "GB-FTS-5606",
"name": "Business Energy and Industrial Strategy",
"identifier": {
"legalName": "Business Energy and Industrial Strategy",
"noIdentifierRationale": "notOnAnyRegister"
},
"address": {
"streetAddress": "1 Victoria Street",
"locality": "London",
"region": "UKI32",
"postalCode": "SW1H0ET",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "VTFContracts@beis.gov.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "01",
"description": "General public services"
}
]
}
},
{
"id": "GB-FTS-66810",
"name": "Moderna Switzerland GmbH",
"identifier": {
"legalName": "Moderna Switzerland GmbH",
"id": "Company Number: CHE-344.522.989",
"schemeEntered": "Moderna Switzerland GmbH"
},
"address": {
"streetAddress": "Aeschenvorstadt 48",
"locality": "Basel",
"region": "CH",
"postalCode": "4051",
"countryName": "Switzerland"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-24378",
"name": "Department for Business, Energy and Industrial Strategy",
"identifier": {
"legalName": "Department for Business, Energy and Industrial Strategy"
},
"address": {
"locality": "London",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-5606",
"name": "Business Energy and Industrial Strategy"
},
"contracts": [
{
"id": "030205-2022-1",
"awardID": "030205-2022-1",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-11-30T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"language": "en"
}